Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
Neuroimage. 2014 Feb 15;87:89-95. doi: 10.1016/j.neuroimage.2013.10.068. Epub 2013 Nov 10.
[(11)C]NOP-1A is a novel high-affinity PET ligand for imaging nociceptin/orphanin FQ peptide (NOP) receptors. Here, we report reproducibility and reliability measures of binding parameter estimates for [(11)C]NOP-1A binding in the brain of healthy humans. After intravenous injection of [(11)C]NOP-1A, PET scans were conducted twice on eleven healthy volunteers on the same (10/11 subjects) or different (1/11 subjects) days. Subjects underwent serial sampling of radial arterial blood to measure parent radioligand concentrations. Distribution volume (VT; a measure of receptor density) was determined by compartmental (one- and two-tissue) modeling in large regions and by simpler regression methods (graphical Logan and bilinear MA1) in both large regions and voxel data. Retest variability and intraclass correlation coefficient (ICC) of VT were determined as measures of reproducibility and reliability respectively. Regional [(11)C]NOP-1A uptake in the brain was high, with a peak radioactivity concentration of 4-7 SUV (standardized uptake value) and a rank order of putamen>cingulate cortex>cerebellum. Brain time-activity curves fitted well in 10 of 11 subjects by unconstrained two-tissue compartmental model. The retest variability of VT was moderately good across brain regions except cerebellum, and was similar across different modeling methods, averaging 12% for large regions and 14% for voxel-based methods. The retest reliability of VT was also moderately good in most brain regions, except thalamus and cerebellum, and was similar across different modeling methods averaging 0.46 for large regions and 0.48 for voxels having gray matter probability >20%. The lowest retest variability and highest retest reliability of VT were achieved by compartmental modeling for large regions, and by the parametric Logan method for voxel-based methods. Moderately good reproducibility and reliability measures of VT for [(11)C]NOP-1A make it a useful PET ligand for comparing NOP receptor binding between different subject groups or under different conditions in the same subject.
[(11)C]NOP-1A 是一种新型高亲和力正电子发射断层扫描(PET)配体,可用于成像孤啡肽/孤啡肽 FQ 肽(NOP)受体。在此,我们报告了 [(11)C]NOP-1A 在健康人体大脑中的结合参数估计的可重复性和可靠性测量。静脉注射 [(11)C]NOP-1A 后,11 名健康志愿者中,有 10 名(10/11 名)或不同(1/11 名)日进行了两次 PET 扫描。受试者进行连续的桡动脉血样采集,以测量亲代放射性配体浓度。分布容积(VT;受体密度的衡量标准)通过在大区域进行房室(单和双组织)建模以及在大区域和体素数据中使用更简单的回归方法(图形洛根和双线性 MA1)来确定。VT 的复测变异性和组内相关系数(ICC)分别作为可重复性和可靠性的衡量标准。大脑中 [(11)C]NOP-1A 的摄取量较高,放射性活性浓度峰值为 4-7 SUV(标准化摄取值),且纹状体>扣带回皮质>小脑的顺序。在 11 名受试者中的 10 名,脑时间-活性曲线通过无约束的双组织房室模型拟合良好。除小脑外,VT 在大脑各个区域的复测变异性均为中等,且与不同的建模方法相似,大区域的平均变异性为 12%,基于体素的方法为 14%。除丘脑和小脑外,VT 的复测可靠性在大多数大脑区域也中等良好,且与不同的建模方法相似,大区域的平均可靠性为 0.46,体素的灰质概率>20%时为 0.48。通过大区域的房室建模和基于体素的方法中的参数洛根方法,可以实现 VT 的最佳复测变异性和最高复测可靠性。[(11)C]NOP-1A 的 VT 具有中等良好的可重复性和可靠性测量值,可用于比较不同受试组或同一受试组在不同条件下的 NOP 受体结合情况。